Over the weekend I read the new, third edition of "The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management," by Martin A. Voet ($28.95 at Amazon). Mr. Voet was ...

Applied’s lead candidate is a selective aldose reductase inhibitor called govorestat, an asset that failed to hit primary endpoints in late-stage trials for a progressive neuromuscular disease called ...

New York - February 8, 2012 - Eagle Genomics and Cycle Computing today announced that they have jointly won a competitive bid by the Pistoia Alliance to support the development of a proof-of-concept ...

Cycle and Aprecia will use Aprecia's 3DP Technology to improve rare disease drug formulations. Aprecia Pharmaceuticals and Cycle Pharmaceuticals signed a partnership agreement to develop and ...

While the optimization of a lyophilization cycle for a biologic relies on a well-characterized formulation, viscosity and aggregation after product reconstitution must also be carefully managed. The ...

Cycle Group Holdings Limited will acquire by the pharmaceutical company Applied Therapeutics.

The National Community Pharmacists Association said Tuesday that it fully supports a proposed rule from the Centers for Medicare & Medicaid Services that requires pharmacies to only dispense brand ...

ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, announced the release of a new two-part white paper series, AI-Digital-Physical Convergence: ...

Andrew Anderson shares insights on the factors that may shape the next major advance in pharmaceutical informatics strategy.